U.S., Feb. 6 -- ClinicalTrials.gov registry received information related to the study (NCT06808334) titled 'CLAiR Pivotal Study' on Jan. 27.

Brief Summary: This is a multi-site, observational clinical study to validate the performance of the CLAiR AI software in identifying elevated atherosclerotic cardiovascular disease (ASCVD) risk from retinal (eye) images obtained from two different retinal image camera models.

Study Start Date: Feb. 01

Study Type: OBSERVATIONAL

Condition: No Condition

Intervention: OTHER: CLAIR

Subject will have retinal images obtained and uploaded to CLAiR Software. Subjects are not directly in contact with CLAiR software. There is no medical intervention.

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Toku...